Dec 23 (Reuters) - Immuron Ltd (IMC) :
- IMMURON RECEIVES FDA APPROVAL FOR TRAVELAN IND APPLICATION
- IMMURON LTD - PLANS IN PLACE TO INITIATE A HUMAN CLINICAL TRIAL IN 60 HEALTHY VOLUNTEERS IN USA
- IMMURON LTD - PLANS IN PLACE TO INITIATE A HUMAN CLINICAL TRIAL IN 60 HEALTHY VOLUNTEERS IN USA
- IMMURON LTD - RECRUITMENT IS PLANNED TO BE INITIATED IN 1H 2023 WITH HEADLINE RESULTS FROM CLINICAL TRIAL EXPECTED TO BE REPORTED BY YEAR END 2023
Add to My Watchlist
What is My Watchlist?